Story Health WHO

WHO sounds alarm on antimicrobial resistance threat

Health
The brief

The spread of antimicrobial resistance (AMR) is threatening modern medicine despite progress in combating drug-resistant bacteria, senior World Health Organization officials said Monday. Officials said countries had expanded efforts to tackle AMR, but warned that progress in prevention, diagnosis and the appropriate use of antibiotics remained too slow to meet global targets. Bacteria have long evolved resistance to medicines designed to kill them, and the widespread use of antibiotics in human health, animal husbandry and food production has accelerated the problem, making AMR one of the leading causes of infectious disease deaths worldwide.

Jean-Pierre Nyemazi, interim head of antimicrobial resistance at the WHO, said that "antimicrobial resistance is widespread and threatening the future of modern medicine." Unlike COVID-19, he said, drug-resistant infections have been taking lives for years without drawing the alarm they should. The agency said AMR was directly responsible for more than one million deaths in 2021 alone and linked to some 4.7 million others.S1S2

A WHO investigation covering 183 countries found that nearly nine in ten now have a national action plan against AMR, up from around four in ten in 2017. However, only 42 countries, fewer than one in five, said their plan was financed, implemented and monitored, said Pravasha Prakash, an AMR technical officer with the agency. Prakash added that countries are moving forward at every step, but progress must be speeded up to reach the 2030 targets.S1S2

Access to diagnostics remains one of the main weaknesses. Only 36 percent of countries had a national reference laboratory capable of testing for resistance in all bacteria and fungi monitored by the WHO, well short of the 80 percent target set for 2030. Sylvia Bertagnolo, head of AMR surveillance at the WHO, warned that without testing, clinicians must treat infections without knowing their cause or which antibiotic will work. Global surveillance data show that in 2023, one in every six laboratory-confirmed bacterial infections reported to the WHO was resistant to the antibiotics used to treat it.S1S2

In response, the WHO has released two new tools to help countries strengthen diagnostic capacity. The first defines the tests that should be available at every level of the health system, from primary care centres to referral hospitals. The second compiles 73 laboratory procedures, from sample collection to pathogen identification and antibiotic susceptibility testing. The WHO has estimated that AMR could cause some 39 million deaths between now and 2050, and officials stressed the need for better use of existing antibiotics at a time when development of new treatments is failing to keep pace with rising resistance.S1S2

Timeline · newest first
1h Medicalxpress

WHO sounds the alarm on antimicrobial resistance threat

The spread of antimicrobial resistance (AMR) is threatening modern medicine despite progress in combating drug-resistant bacteria, senior World Health Organization officials said M…

WHO sounds alarm on antimicrobial resistance threat

2 outlets 2 reports
The brief

The spread of antimicrobial resistance (AMR) is threatening modern medicine despite progress in combating drug-resistant bacteria, senior World Health Organization officials said Monday. Officials said countries had expanded efforts to tackle AMR, but warned that progress in prevention, diagnosis and the appropriate use of antibiotics remained too slow to meet global targets. Bacteria have long evolved resistance to medicines designed to kill them, and the widespread use of antibiotics in human health, animal husbandry and food production has accelerated the problem, making AMR one of the leading causes of infectious disease deaths worldwide.

Jean-Pierre Nyemazi, interim head of antimicrobial resistance at the WHO, said that "antimicrobial resistance is widespread and threatening the future of modern medicine." Unlike COVID-19, he said, drug-resistant infections have been taking lives for years without drawing the alarm they should. The agency said AMR was directly responsible for more than one million deaths in 2021 alone and linked to some 4.7 million others.S1S2

A WHO investigation covering 183 countries found that nearly nine in ten now have a national action plan against AMR, up from around four in ten in 2017. However, only 42 countries, fewer than one in five, said their plan was financed, implemented and monitored, said Pravasha Prakash, an AMR technical officer with the agency. Prakash added that countries are moving forward at every step, but progress must be speeded up to reach the 2030 targets.S1S2

Access to diagnostics remains one of the main weaknesses. Only 36 percent of countries had a national reference laboratory capable of testing for resistance in all bacteria and fungi monitored by the WHO, well short of the 80 percent target set for 2030. Sylvia Bertagnolo, head of AMR surveillance at the WHO, warned that without testing, clinicians must treat infections without knowing their cause or which antibiotic will work. Global surveillance data show that in 2023, one in every six laboratory-confirmed bacterial infections reported to the WHO was resistant to the antibiotics used to treat it.S1S2

In response, the WHO has released two new tools to help countries strengthen diagnostic capacity. The first defines the tests that should be available at every level of the health system, from primary care centres to referral hospitals. The second compiles 73 laboratory procedures, from sample collection to pathogen identification and antibiotic susceptibility testing. The WHO has estimated that AMR could cause some 39 million deaths between now and 2050, and officials stressed the need for better use of existing antibiotics at a time when development of new treatments is failing to keep pace with rising resistance.S1S2

Timeline · newest first

Sources · 2 citations

S1 Medicalxpress 1 report · EN
S2 Asharq Al-AwsatLead 1 report · EN